Corporate Information And Statement Of Ifrs Compliance [Abstract]

PCI Biotech Holding - Filing #5867918

Concept	As at 2024-12-31	2024-01-01 to 2024-12-31	As at 2023-12-31
Corporate information and statement of IFRS compliance [abstract]
Name of reporting entity or other means of identification	—	PCI Biotech Holding ASA	—
Legal form of entity	—	ASA	—
Country of incorporation	—	Norway	—
Address of entity's registered office	—	Ullernchausséen 64, N-0379 Oslo	—
Description of nature of entity's operations and principal activities	—	1. Corporate information	—
Statement of IFRS compliance [text block]	—	2.1 Basis of preparation	—
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [text block]	—	—	—
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [abstract]
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [line items]
Current trade payables	1 722 NOK	—	712,000 NOK